msJAMA. Genomics in medicine and public health: role of cost-effectiveness analysis.
Goldie
S J
SJ
Harvard School of Public Health, Boston, MA, USA.
Levin
A R
AR
D003362:Cost-Benefit Analysis; D030342:Genetic Diseases, Inborn / Q000191:economics* / Q000517:prevention & control; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000191:economics*; D006801:Humans; D011315:Preventive Medicine / Q000191:economics